# Pamoja Capital

> Pamoja Capital is a VC fund in Luxembourg backing Health Care and Wellness. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Luxembourg, Luxembourg
- Total investments: 4
- Last investment: Apr 2022
- Lead investor: 25%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/pamoja-capital/
- Website: http://www.pamojacapital.com/

Pamoja Capital is a VC fund in Luxembourg focused on Health Care and Wellness. The Pamoja Capital Group is a private investment firm founded in 2006 by John McCall MacBain and his team following the sale of Trader Classified Media. Pamoja means “togetherness in Swahili.Pamoja Capital Group creates value through long-term, socially-responsible, global investments across a number of industry sectors, including education,life sciences, information technology, real estate and media and communications.The firm's investments span all stages of corporate growth, including seed and growth capital. The firm places special emphasis on investing in businesses with sustainable cash flow. Pamoja Capital Group believes that the experience of its managers in operating global businesses, combined with the long-term orientation of its financial resources, gives its portfolio companies a distinct competitive advantage.

## Contacts

5 contacts available for Pamoja Capital. Shizune tracks 1 team members at Pamoja Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/pamoja-capital-group?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series B | $25M–$115M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 75% |
| Wellness | 1 | 25% |
| Organic Food | 1 | 25% |
| Therapeutics | 1 | 25% |
| Biotechnology | 1 | 25% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 50% |
| Seed | 1 | 25% |
| Pre-Seed | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 50% |
| Poland | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| John H. McCall MacBain | Founder | 0 | https://shizune.co/investors/profile/john-h-mccall-macbain |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Mindgram | Mindgram is a science-based platform and mobile app for complete mental wellness. | $7.7M | Seed | Apr 04, 2022 | https://mindgram.com/ |
| The Nue Co. | The Nue Co. was born after a trip to Copenhagen inspired them to create a supplement brand founded on two danish principles, simplicity and creativity.Their lab has over 20 years experience and is based in Cambridge, England. Rather than working with harsh, isolated vitamins they choose to work with powerful organic foods high in specificvitamins or minerals. Every ingredient they use is completely traceable and of the highest standard. They never add fillers of any type, making their blends potent and pure.They limit the use of plastic packaging and are focused on minimising their carbon footprint. | $25M | Series B | Jul 15, 2021 | https://www.thenueco.com/ |
| Mindgram | Mindgram is a science-based platform and mobile app for complete mental wellness. | $2.2M | Pre-Seed | Apr 20, 2021 | https://mindgram.com/ |
| Talaris Therapeutics | Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies. The company's proprietary allogeneic cell therapy product has shown to induce tolerance in recipients of solid organ transplants from unmatched and unrelated donors, enabling living donor kidney transplant recipients towean completely off immunosuppression one year after transplant. | $115M | Series B | Oct 06, 2020 | https://talaristx.com/ |

4 of 4 investments shown.

## Co-investors
- [Market One Capital](https://shizune.co/investors/profile/market-one-capital) — VC Fund, 2 deals together
- [Aisling Capital](https://shizune.co/investors/profile/aisling-capital) — VC Fund, 1 deal together
- [Blackstone Life Sciences](https://shizune.co/investors/profile/blackstone-life-science) — VC Fund, 1 deal together
- [Cormorant Asset Management](https://shizune.co/investors/profile/cormorant-asset-management) — VC Fund, 1 deal together
- [Credo Ventures](https://shizune.co/investors/profile/credo-ventures) — VC Fund, 1 deal together
- [Eventide](https://shizune.co/investors/profile/eventide-asset-management) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [SpeedUp Venture Capital Group](https://shizune.co/investors/profile/speedup-venture-capital-group) — VC Fund
- [SMOK Ventures](https://shizune.co/investors/profile/smok-ventures) — VC Fund
- [LT Capital](https://shizune.co/investors/profile/lt-capital-5861) — VC Fund

## Featured in investor lists
- [Wellness Investors in Poland](https://shizune.co/investors/wellness-investors-poland)
- [Wellness VC Funds in Poland](https://shizune.co/investors/wellness-vc-funds-poland)

## FAQ

### What does Pamoja Capital invest in?

Pamoja Capital invests primarily in Health Care, Wellness and Organic Food startups, most often at Series B and Seed stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Pamoja Capital's check size?

Pamoja Capital typically joins rounds of $25M–$115M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Pamoja Capital participates in.

### How do I contact Pamoja Capital?

Public channels for Pamoja Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Pamoja Capital?

The team at Pamoja Capital includes John H. McCall MacBain (Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co